Animal Diagnostics Market
By Product;
Growing Trend of Adopting Pet Animals, Rising Prevalence of Food Borne and Zoonotic Diseases, Favorable Government Initiatives, Rapidly Increasing Demand for Animal Products, and Advancements in Veterinary DiagnosticsBy Technology;
Immunodiagnostics - [ELISA, Lateral Flow Assays, Immunoassay Analyzers] and Others, Clinical Biochemistry, Hematology and Molecular Diagnostics - [PCR, Microarrays] and Others, Urinalysis, Others, and Ambulatory Surgical CentersBy Animal Type;
Farm Animals - Poultry, Swine, Cattle and Others, Companion animals - Dogs, Cats, Horses, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Animal Diagnostics Market Overview
Animal Diagnostics Market (USD Million)
Animal Diagnostics Market was valued at USD 4,798.01 million in the year 2024. The size of this market is expected to increase to USD 7,960.13 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.5%.
Animal Diagnostics Market
*Market size in USD million
CAGR 7.5 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 7.5 % |
Market Size (2024) | USD 4,798.01 Million |
Market Size (2031) | USD 7,960.13 Million |
Market Concentration | Medium |
Report Pages | 362 |
Major Players
- BioMerieux SA
- Heska Corporation
- Idexx Laboratories
- IDVet
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Virbac Corporation
- Zoetis Inc.
- BIOCHEK BV
- INDICAL Bioscience GmbH
- Neogen Corporation
- Bio-Rad Inc.
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Animal Diagnostics Market
Fragmented - Highly competitive market without dominant players
The Animal Diagnostics Market is experiencing significant growth as veterinary clinics and livestock operations intensify disease surveillance and routine health screening. Nearly 60% of practices now include routine diagnostic panels, boosting early disease detection rates. This surge creates compelling opportunities for developers of point‑of‑care devices and lab-based testing platforms. Training initiatives for vets and farm managers are driving expansion, and preventative care awareness is growing. Together, these elements support continuous adoption across diverse animal care settings.
Point‑of‑Care Testing Transforming Veterinary Workflow
Recent technological advancements include handheld analyzers, rapid multiplex assays, and digital readers tailored for in-field use. Around 65% of clinics now adopt these solutions, reducing turnaround time and enhancing treatment decisions. These tools elevate clinical confidence and simplify workflow efficiency. As a result, adoption is deepening across companion animals, equine, and large-animal sectors—fostering stronger growth and expansion.
Smart Implementation Enhancing Accessibility
Providers are deploying strategies like bundled wellness panels, tele‑consultation integration, and training modules for on-site testing. These initiatives have resulted in about 70% of animal health providers offering branded diagnostic programs. These efforts improve service adoption, foster preventive screening, and support ongoing care plans. They also enhance patient (animal) outcome tracking through mobile apps—fueling consistent expansion.
Digital Integration Shaping Future Veterinary Care
The future outlook emphasizes innovation such as AI-based disease predictors, connected diagnostic platforms, and cloud‑based result repositories. Over 75% of new systems now incorporate data analytics or telehealth interfaces. These technological advancements will enable personalized diagnostics, epidemiological tracking, and proactive herd management. As smart diagnostics gain acceptance, the market is positioned for sustained growth and deeper expansion into integrated veterinary care ecosystems.
Animal Diagnostics Market Recent Developments
-
In August 2022, PepiPets launched a new mobile diagnostic testing service. Launching this new service in a company release will allow clients to receive diagnostic testing at home for their pets. PepiPets hopes the at-home testing service will help pets feel more comfortable with the procedure and save time on travel to an in-person office visit.
-
In March 2022, Companion Animal Health promulgated a strategic agreement, including an equity investment, with HT BioImaging to co-brand and exclusively sell the HTVet product in the US and Canada.
Animal Diagnostics Market Segment Analysis
In this report,The Animal Diagnostics Market has been segmented by Product, Technology, Animal Type and Geography.
Animal Diagnostics Market, Segmentation by Product
The Animal Diagnostics Market has been segmented by Product into Growing trend of adopting pet animals, Rising Prevalence of Food Borne and Zoonotic Diseases, Favorable Government Initiatives, Rapidly Increasing Demand for Animal Products and Advancements in Veterinary Diagnostics.
Growing Trend of Adopting Pet Animals
The growing trend of pet adoption contributes to nearly 28% of the animal diagnostics market. Rising pet humanization, especially in urban areas, has led to increased spending on veterinary healthcare and diagnostics. Pet owners are increasingly opting for preventive screenings and routine diagnostic tests to ensure animal well-being.
Rising Prevalence of Food Borne and Zoonotic Diseases
This segment holds around 24% of the market due to the global concern over zoonotic infections such as salmonellosis, brucellosis, and avian influenza. The growing focus on food safety and animal-to-human disease transmission is increasing the demand for rapid and accurate diagnostic tools in both livestock and companion animals.
Favorable Government Initiatives
Government initiatives contribute to approximately 18% of the market. Regulatory bodies across regions are supporting animal health programs, promoting mass vaccination drives, and investing in epidemiological surveillance. These efforts are boosting the adoption of diagnostic kits for early disease detection and control.
Rapidly Increasing Demand for Animal Products
This segment accounts for around 20% of the market, driven by the rising global demand for milk, meat, and eggs. Healthy livestock is essential for ensuring productivity and safety, which is increasing the reliance on diagnostic solutions for early identification of infectious and metabolic diseases.
Advancements in Veterinary Diagnostics
Technological advancements make up about 10% of the market, with innovations such as molecular diagnostics, point-of-care testing, and next-generation sequencing. These tools enable quick and precise diagnosis of complex animal diseases, enhancing treatment outcomes and reducing the risk of outbreaks.
Animal Diagnostics Market, Segmentation by Technology
The Animal Diagnostics Market has been segmented by Technology into Immunodiagnostics - ELISA, Lateral flow assays, Immunoassay analyzers and Others, Clinical biochemistry, Hematology and Molecular diagnostics - PCR, Microarrays and Others, Urinalysis, Others and Ambulatory surgical centers.
Immunodiagnostics – ELISA, Lateral Flow Assays, Immunoassay Analyzers and Others
Immunodiagnostics dominate the market, accounting for approximately 35% of the technology segment. Tools like ELISA and lateral flow assays are widely used for the detection of antigens and antibodies in companion and livestock animals. The high sensitivity, specificity, and ease of use contribute to their extensive adoption.
Clinical Biochemistry
Clinical biochemistry holds about 20% of the market and plays a vital role in evaluating organ function and metabolic conditions in animals. This includes analyzing electrolytes, enzymes, and biomarkers from blood and serum samples to support diagnosis and treatment planning.
Hematology
Hematology contributes approximately 15% of the market. It focuses on the quantitative and qualitative analysis of blood components such as RBCs, WBCs, and platelets. This method is critical for identifying infections, anemia, and immune responses in both domestic and farm animals.
Molecular Diagnostics – PCR, Microarrays and Others
Molecular diagnostics represent nearly 18% of the market and are rapidly gaining traction due to their high precision in identifying pathogen DNA or RNA. Techniques such as PCR and microarrays are widely used for early detection of zoonotic infections, genetic screening, and disease surveillance.
Urinalysis
Urinalysis makes up about 7% of the technology segment. It helps in diagnosing urinary tract infections, kidney disorders, and metabolic abnormalities. The ease of sample collection and integration with point-of-care devices enhances its utility in clinical veterinary practice.
Others
The 'Others' category, contributing roughly 5%, includes cytology, endocrinology testing, and other niche diagnostic techniques. These methods are typically used in specialty veterinary centers and research applications for in-depth diagnostic evaluations.
Ambulatory Surgical Centers
*Note: Ambulatory Surgical Centers appear to be miscategorized under Technology instead of End User.* However, in relevant markets, these centers may utilize rapid diagnostics and point-of-care testing technologies to support preoperative screening and postoperative care in animals.
Animal Diagnostics Market, Segmentation by Animal Type
The Animal Diagnostics Market has been segmented by Animal Type into Farm animals - Poultry, Swine, Cattle and Others, Companion animals - Dogs, Cats, Horses and Others.
Farm Animals – Poultry
Poultry represents approximately 22% of the animal diagnostics market, driven by the need for disease prevention in high-density farming. Common diagnostics focus on avian influenza, Newcastle disease, and salmonellosis. The growing global demand for poultry meat and eggs is propelling routine health screening practices.
Farm Animals – Swine
Swine diagnostics account for around 18% of the market. Regular testing for porcine reproductive and respiratory syndrome (PRRS), swine fever, and other infectious diseases is critical for minimizing economic losses. The push for biosecurity and livestock traceability supports the demand for advanced diagnostic tools.
Farm Animals – Cattle
Cattle hold a market share of about 20%, driven by the necessity for early detection of diseases like bovine tuberculosis, mastitis, and foot-and-mouth disease. With increasing global consumption of dairy and beef products, maintaining herd health through diagnostics is a key priority for producers.
Farm Animals – Others
This segment, comprising animals such as goats, sheep, and aquaculture species, makes up around 10% of the farm animal diagnostics market. These animals are critical for regional agriculture economies, especially in developing countries where disease outbreaks significantly impact productivity.
Companion Animals – Dogs
Dogs lead the companion animal diagnostics segment, contributing approximately 15% of the overall market. Diagnostic tests commonly screen for tick-borne illnesses, parasitic infections, and chronic conditions such as diabetes and renal disease. Rising pet ownership and spending on pet care fuel demand in this category.
Companion Animals – Cats
Cats represent nearly 9% of the market, with increasing demand for diagnostic screening for feline leukemia, kidney disorders, and urinary tract infections. Indoor pet care and regular preventive checkups are driving adoption of feline-specific diagnostic panels.
Companion Animals – Horses
Horses account for roughly 4% of the companion animal diagnostics segment. Diagnostics are often used for laminitis, equine infectious anemia, and respiratory disorders. The market is supported by equine sports and breeding programs that demand high levels of health monitoring.
Companion Animals – Others
The ‘Others’ category includes small mammals, birds, and exotic pets, contributing about 2% to the total market. While niche, this segment is growing due to increased urban pet diversity and demand for species-specific diagnostic capabilities in veterinary clinics.
Animal Diagnostics Market, Segmentation by Geography
The Animal Diagnostics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Regions and Countries Analyzed in this Report
Animal Diagnostics Market Share (%), by Geographical Region
North America
North America leads the animal diagnostics market with a share of approximately 38%, supported by high pet ownership rates, advanced veterinary infrastructure, and increasing demand for preventive animal healthcare. The U.S. is the largest contributor due to strong research investment and widespread use of diagnostic technologies in both livestock and companion animals.
Europe
Europe accounts for nearly 27% of the market, driven by stringent animal welfare regulations, government-funded veterinary programs, and high awareness of zoonotic disease risks. Countries like Germany, the UK, and France are leading adopters of molecular diagnostics and point-of-care testing in veterinary practice.
Asia Pacific
Asia Pacific holds around 20% of the market and is expected to grow rapidly due to increasing livestock farming, pet adoption, and rising concerns over animal-borne diseases. Markets such as China, India, and Japan are investing in veterinary infrastructure and expanding access to modern diagnostics.
Middle East and Africa
The Middle East and Africa region contribute approximately 8% to the global market. The demand is rising with growing attention toward animal health monitoring in commercial farming and public health sectors. Efforts to control zoonotic outbreaks and develop veterinary laboratories are boosting diagnostics adoption.
Latin America
Latin America represents around 7% of the market, with Brazil and Mexico as key contributors. The region is witnessing steady growth due to increasing animal disease surveillance, livestock productivity initiatives, and the expansion of private veterinary clinics focused on companion animal diagnostics.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Animal Diagnostics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers:
- Advancements in Diagnostic Technologies
- Increasing Demand for Animal Health Monitoring
- Rising Incidence of Zoonotic Diseases
-
Growing Investments in Veterinary Healthcare: The global animal diagnostics market is experiencing significant growth due to increasing investments in veterinary healthcare worldwide. As awareness of animal health and welfare rises, there is a corresponding increase in funding for veterinary services and diagnostics. These investments are driven by various factors, including the growing demand for safe and high-quality animal products, such as meat, milk, and eggs, which necessitates stringent disease monitoring and control measures in livestock. Additionally, the rising trend of pet humanization, particularly in developed regions, is boosting expenditure on companion animal healthcare, including diagnostics for early disease detection and preventive care.
Governments and private entities are allocating resources to enhance veterinary infrastructure, expand diagnostic capabilities, and improve access to healthcare services for both farm and companion animals. This includes investments in state-of-the-art diagnostic technologies such as molecular diagnostics, point-of-care testing, and advanced imaging modalities. These advancements enable veterinarians to diagnose diseases more accurately and efficiently, leading to better treatment outcomes and overall animal health management. Furthermore, collaborations between veterinary clinics, diagnostic laboratories, and research institutions are fostering innovation in diagnostic tools and methodologies, driving the growth of the global animal diagnostics market.
Restraints:
- Complex Regulatory Frameworks
- Challenges in Standardization and Quality Assurance
- Shortage of Skilled Veterinary Professionals
-
Ethical Concerns and Public Perception: Ethical concerns and public perception significantly influence the global animal diagnostics market, shaping regulatory landscapes and market dynamics. One major ethical consideration revolves around the welfare of animals used in diagnostic testing. There is ongoing debate regarding the ethical treatment of animals in research and testing practices, especially in invasive procedures or when testing involves discomfort or harm to animals. Ethical guidelines and regulations aim to balance the need for diagnostic advancements with animal welfare standards, prompting the adoption of alternative testing methods and refining existing techniques to minimize animal suffering.
Public perception also plays a crucial role, as societal attitudes towards animal testing impact consumer behaviors, regulatory decisions, and industry practices. Increased awareness and advocacy for animal rights have led to greater scrutiny of veterinary practices and diagnostic procedures, influencing market trends towards non-invasive and humane testing methods. Manufacturers and healthcare providers in the animal diagnostics sector are increasingly transparent about their ethical standards and practices, aiming to build trust with consumers and stakeholders. As public awareness grows, there is a growing preference for products and services that align with ethical principles, driving innovation towards more ethical and sustainable practices within the global animal diagnostics market.
Opportunities:
- Technological Innovations in Diagnostic Tools
- Expanding Companion Animal Healthcare
- Increasing Demand for Livestock Disease Management
-
Growing Focus on Preventive Veterinary Care: The global animal diagnostics market is witnessing a growing emphasis on preventive veterinary care, driven by the recognition of its role in improving animal health outcomes and reducing healthcare costs. Preventive veterinary care involves regular health assessments, vaccinations, and diagnostic screenings aimed at detecting and addressing potential health issues before they become severe. This proactive approach not only enhances the overall well-being of animals but also supports sustainable agricultural practices by minimizing disease outbreaks and improving productivity in livestock.
Veterinary clinics and diagnostic laboratories are increasingly integrating preventive care services into their offerings, utilizing advanced diagnostic tools such as blood tests, urinalysis, and imaging techniques to assess animal health comprehensively. These diagnostics help veterinarians identify early signs of diseases, monitor changes in health parameters, and implement timely interventions to prevent the progression of illnesses. The shift towards preventive veterinary care is further supported by educational campaigns, regulatory initiatives promoting vaccination programs, and the adoption of best practices in animal husbandry. As stakeholders across the veterinary healthcare sector prioritize proactive health management strategies, the global animal diagnostics market is poised for growth, driven by innovations in preventive care and a commitment to improving animal welfare worldwide.
Competitive Landscape Analysis
Key players in Global Animal Diagnostics Market include:
- BioMerieux SA
- Heska Corporation
- Idexx Laboratories
- IDVet
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Virbac Corporation
- Zoetis Inc.
- BIOCHEK BV
- INDICAL Bioscience GmbH
- Neogen Corporation
- Bio-Rad Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
- Animal Diagnostics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Advancements in Diagnostic Technologies
-
Increasing Demand for Animal Health Monitoring
-
Rising Incidence of Zoonotic Diseases
-
Growing Investments in Veterinary Healthcare
-
- Restraints
-
Complex Regulatory Frameworks
-
Challenges in Standardization and Quality Assurance
-
Shortage of Skilled Veterinary Professionals
-
Ethical Concerns and Public Perception
-
- Opportunities
-
Technological Innovations in Diagnostic Tools
-
Expanding Companion Animal Healthcare
-
Increasing Demand for Livestock Disease Management
-
Growing Focus on Preventive Veterinary Care
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Animal Diagnostics Market, By Product, 2021 - 2031 (USD Million)
- Growing Trend of Adopting Pet Animals
- Rising Prevalence of Food Borne and Zoonotic Diseases
- Favorable Government Initiatives
- Rapidly Increasing Demand for Animal Products
- Advancements in Veterinary Diagnostics
- Animal Diagnostics Market, By Technology, 2021 - 2031 (USD Million)
- Immunodiagnostics
- ELISA
- Lateral flow assays
- Immunoassay analyzers
- Clinical biochemistry
- Hematology
- Molecular diagnostics
- PCR
- Microarrays
- Urinalysis
- Ambulatory surgical centers
- Immunodiagnostics
- Animal Diagnostics Market, By Animal Type, 2021 - 2031 (USD Million)
- Farm animals
- Poultry
- Swine
- Cattle
- Companion animals
- Dogs
- Cats
- Horses
- Farm animals
- Animal Diagnostics Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Animal Diagnostics Market, By Product, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- BioMerieux SA
- Heska Corporation
- Idexx Laboratories
- IDVet
- Randox Laboratories Ltd.
- Thermo Fisher Scientific Inc.
- Virbac Corporation
- Zoetis Inc.
- BIOCHEK BV
- INDICAL Bioscience GmbH
- Neogen Corporation
- Bio-Rad Inc.
- Company Profiles
- Analyst Views
- Future Outlook of the Market